KnowTheStock
Log inCreate free account

Resmed Inc.

RMD
S&P 500Surgical and Medical Instrument Manufacturing · NEW YORK STOCK EXCHANGE INC.
$198.43last close · market cap 28.98 Billion
Compare with…
87.3SCORE / 100
Our verdictHOLDStrong Growth and ImprovingFY Ending 2026-06-30 · trend positive

Why Hold

Income statement, balance sheet and cash flow are strong.

Next earnings: 2026-10-29 (AMC), EPS Forecast: $2.67

What is strong
  • Net Margin is 26.94%
  • Current Asset to Current Liability Ratio is 3.1
  • Debt Ratio is 0.27
  • Current Debt to Net Income Ratio is 0.17
  • Total Debt to Total Assets Ratio is 0.04
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Revenue Growth is 9.85%
  • Operating Income Growth is 11.95%
  • Net Income Growth is 8.75%
  • Earnings Per Share (EPS) Growth is 9.67%
  • Cash from Operations Growth is 3.1%

What changed

Score by quarter

Upgraded from Sell to Hold in the Dec 2022 quarter: 73.0 → 73.5 (+0.5). This quarter: +2.7.

708090Sep 2022Mar 2026

What the score is made of

Income statement91.8 +0.4
Balance sheet79.2 +8.3
Cash flow89.7 +0.0

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)5.65 Billion9.85 % growth
EPS10.439.67 % growth
Profit margin26.94 %Profit per $1 of sales
P-E ratio—Not available
Market cap28.98 BillionShares × price
Debt-equity ratio0.06Leverage
Dividend2.40Per share, annual
Next earnings2026-10-29AMC · EPS forecast $2.67
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Resmed Inc.

at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.

CEO
Michael Farrell
Employees
5,138
Sector
Manufacturing
Exchange
NEW YORK STOCK EXCHANGE INC.
resmed.com

Similar stocks

Loading…